The prophylaxis of rat and mouse mammary gland tumorigenesis by suppression of prolactin secretion: A reappraisal
- 1 September 1981
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 1 (3) , 225-232
- https://doi.org/10.1007/bf01806262
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The cause of species differences in mammary tumourigenesis: Significance of mammary gland DNA synthesisMedical Hypotheses, 1979
- Reduction of Serum Prolactin in Rats by 2 Ergot Alkaloids and 2 Ergoline Derivatives: A ComparisonExperimental Biology and Medicine, 1974
- Comparative effects of hypophysectomy, ergocornine and ergocornine‐reserpine treatments on rat mammary carcinomaInternational Journal of Cancer, 1973
- Effects of 2-Br-α-ergocryptine on plasma prolactin level and milk yield in cowsCellular and Molecular Life Sciences, 1972
- Rat mammary cancer inhibition by a prolactin suppressor, 2-bromo-α-ergokryptine (CB 154)Cellular and Molecular Life Sciences, 1971
- Treatment of Non-puerperal Galactorrhoea with an Ergot AlkaloidBMJ, 1971
- Inhibition of DMBA-Induced Mammary Carcinogenesis in the Rat by 2-Br-α-Ergocryptine (CB 154), An Inhibitor of Prolactin Secretion, and by Nafoxidine (U-11, 100 A), an Estrogen AntagonistGynecologic and Obstetric Investigation, 1971
- Suppression of Mammary Hyperplastic Nodule Formation and Pituitary Prolactin Secretion in Mice Induced by Ergocornine or 2-Bromo-α-ergocryptineJNCI Journal of the National Cancer Institute, 1970
- World Maps of Cancer Mortality Rates and Frequency RatiosJNCI Journal of the National Cancer Institute, 1968
- Mammary Cancer Induced by a Single Feeding of Polynuclear Hydrocarbons, and its SuppressionNature, 1961